Associate Vice President, I and O, QP2, Oncology Early Development, Global Clinical Development @ Merck
Executive Director, Immune and Oncology, QP2, Oncology Early Development, GCD @ Merck Research Laboratories
Executive Director, Oncology, Vax, Immun and Neuro, Quantitative Pharmacology and Pharmacometrics @ Merck Research Labs
Executive Director, Late Stage, Quantitative Pharmacology and Pharmacometrics @ Merck Research Labs
Executive Director, Modeling and Simulation Dept, Early Stage Development @ Merck Research Labs
Senior Director of Modelling and Simulation @ Merck Inc, Rahway, New Jersey
Senior Research Advisor and Group Leader, Eli Lilly @ Eli Lilly and Company
Head of PK and PD, UK @ Eli Lilly
Principal Research Scientist @ Eli Lilly
Dinesh De Alwis's Education
The University of Manchester
PhD (Pharmacokinetics/Pharmacodynamics)
1993 - 1997
Dinesh De Alwis's Skills
Oncology
PK/PD
Clinical Development
Pharmacology
Drug Development
Drug Discovery
Clinical Pharmacology
Pharmaceutical Industry
Clinical Trials
Pharmacometrics
Dinesh De Alwis's Summary
Dinesh De Alwis, based in Somerville, MA, US, is currently a Senior Vice President, Clinical Drug Development, Generate Biomedicines at Generate Biomedicines, bringing experience from previous roles at Merck, Merck Research Laboratories and Merck Research Labs. Dinesh De Alwis holds a 1993 - 1997 PhD in Pharmacokinetics/Pharmacodynamics @ The University of Manchester. With a robust skill set that includes Oncology, PK/PD, Clinical Development, Pharmacology, Drug Development and more, Dinesh De Alwis contributes valuable insights to the industry. Dinesh De Alwis has 2 emails on RocketReach.